// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship Format (SDRF)-Proteomics. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is: HUPO-PSI SDRF.\n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often prevents dat",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "CN COLUMN TIP USE HTML CS EW README SP VK CF ALL sex PATCH LIMITED SHALL PARTICULAR INFORMATION FOR MOD organism part DIA ID MT NCI IDF COULD OR IMPLIED WILL cleavage agent details TA PO PMCID CPTAC MUST XML ANY PRIDE:0000833 MINOR sample MS:1001251 MAY AND SAMEA organism III DJ RFC RECOMMEND HANCESTRO SRM MIAPE IS NOT CELL PS PATO MHC ... STANDARDS QY EM HEREIN mass SWATH NCIT:C25714 ROW MS:1000484 disease stage PMID PTM source name ENVO HUPO II WARRANTIES BMC MS RIGHTS PRIDE:0000831 not PRIDE:0000659 TAB SN PATO:0000461 NT EBI BUT REQUIRED EFO FDR IMPORTANT DISCLAIMS PSI cell type spiked compound BE technical replicate CT PRIDE:0000590 MAGE MIAME INCLUDING YAML URI SILAC MC instrument HCD age BTO TO LC FITNESS proteomics data acquisition method THE individual NOTE NCBI REQUIRES SAMN OF WARRANTY data file ZFA file your PRM NCIT:C25683 INITIATIVE CLO PURPOSE UBERON AC disease TMT pooled sample RAW VCF DOID RECOMMENDED MONDO THAT SHOULD AS LI SDRF MERCHANTABILITY FAIR INFRINGE DDA PROTEOMICS ancestry category developmental stage URL CL biosample accession number CV NCIT ISA HLA PRIDE:0000834 PRIDE OPTIONAL characteristics EXPRESS biological replicate fraction identifier PRIDE:0000832 BRENDA label MAJOR JA HF exclamation PP PEPTIDESEQ"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship Format (SDRF)-Proteomics. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is: HUPO-PSI SDRF.\n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often prevents dat",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "CN COLUMN USE HTML CS EW README SP VK CF ALL sex PATCH LIMITED SHALL PARTICULAR INFORMATION FOR MOD organism part DIA MT OR NCI IDF COULD IMPLIED WILL cleavage agent details TA PO PMCID CPTAC MUST ANY PRIDE:0000833 MINOR MS:1001251 MAY AND SAMEA organism III DJ RFC RECOMMEND HANCESTRO SRM MIAPE IS NOT CELL PS PATO MHC ... STANDARDS QY EM HEREIN mass SWATH NCIT:C25714 ROW MS:1000484 disease stage PMID PTM ENVO HUPO II WARRANTIES BMC MS RIGHTS PRIDE:0000831 PRIDE:0000659 TAB SN PATO:0000461 NT EBI BUT REQUIRED EFO FDR DISCLAIMS PSI cell type spiked compound BE technical replicate CT PRIDE:0000590 MAGE MIAME INCLUDING YAML URI SILAC MC instrument HCD age BTO TO LC FITNESS proteomics data acquisition method THE individual NCBI REQUIRES SAMN OF WARRANTY data file ZFA PRM NCIT:C25683 INITIATIVE CLO PURPOSE UBERON AC disease TMT pooled sample RAW VCF DOID RECOMMENDED MONDO THAT SHOULD AS LI SDRF MERCHANTABILITY FAIR INFRINGE DDA PROTEOMICS URL CL biosample accession number CV NCIT ISA HLA PRIDE:0000834 PRIDE OPTIONAL EXPRESS biological replicate fraction identifier PRIDE:0000832 BRENDA label MAJOR JA HF PP PEPTIDESEQ"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\nrattus norvegicus |NCBITaxon:10116 |Rat\ndanio rerio |NCBITaxon:7955 |Zebrafish\ndrosophila melanogaster |NCBITaxon:7227 |Fruit fly\narabidopsis thaliana |NCBITaxon:3702 |Thale cress\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nblood plasma |UBERON:0001969 |Blood plasma\nliver |UBERON:0002107 |Liver tissue\nbrain |UBERON:0000955 |Brain\nheart |UBERON:0000948 |Heart\nkidney |UBERON:0002113 |Kidney\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hou",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "DOID CL:0000236 COVID MONDO CL:0000057 CL:0000624 MONDO:0004989 APP SDRF CL:0000084 CL:0000815 depletion PATO developmental stage CL age PDX UBERON:0002107 MONDO:0100096 MONDO:0004975 CL:0000066 PTM CL:0000235 NOTE NCBI PATO:0001421 xenograft organism part UBERON:0000178 ID UBERON:0002113 enrichment process PATO:0000461 PO UBERON:0001969 MUST synthetic peptide exclamation UBERON disease EFO MONDO:0005148 UBERON:0000948 UBERON:0000955 MAY cell type organism"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\nrattus norvegicus |NCBITaxon:10116 |Rat\ndanio rerio |NCBITaxon:7955 |Zebrafish\ndrosophila melanogaster |NCBITaxon:7227 |Fruit fly\narabidopsis thaliana |NCBITaxon:3702 |Thale cress\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nblood plasma |UBERON:0001969 |Blood plasma\nliver |UBERON:0002107 |Liver tissue\nbrain |UBERON:0000955 |Brain\nheart |UBERON:0000948 |Heart\nkidney |UBERON:0002113 |Kidney\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hou",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "DOID CL:0000236 COVID MONDO CL:0000057 CL:0000624 MONDO:0004989 APP SDRF CL:0000084 CL:0000815 depletion PATO developmental stage CL age PDX UBERON:0002107 MONDO:0100096 MONDO:0004975 CL:0000066 PTM CL:0000235 NCBI PATO:0001421 xenograft organism part UBERON:0000178 ID UBERON:0002113 enrichment process PATO:0000461 PO UBERON:0001969 MUST synthetic peptide UBERON disease EFO MONDO:0005148 UBERON:0000948 UBERON:0000955 MAY cell type organism"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "treatment response MONDO HANCESTRO SDRF Dukes stage NCIT:C27971 weight ER dose PR HANCESTRO:0009 TNM staging treatment ancestry category NCIT:C28076 menopausal status NCIT:C15262 sampling time point NCIT NCIT:C27966 NCIT:C28078 NCIT:C65106 NCIT:C71732 TNM CHEBI:28748 breast cancer subtype pre-existing condition compound NCIT:C65107 treatment status body mass index disease stage HIPAA NCIT:C4870 individual CHEBI:27899 IV GDPR organism part Ann Arbor stage MONDO:0005044 ID NCIT:C18206 NCI NCIT:C15632 AJCC tumor grade exclamation NCIT:C53554 NCIT:C65108 MONDO:0005148 smoking status IMPORTANT HANCESTRO:0005"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "treatment response MONDO HANCESTRO SDRF Dukes stage NCIT:C27971 weight ER dose PR HANCESTRO:0009 TNM staging treatment ancestry category NCIT:C28076 menopausal status NCIT:C15262 sampling time point NCIT NCIT:C27966 NCIT:C28078 NCIT:C65106 NCIT:C71732 TNM CHEBI:28748 breast cancer subtype pre-existing condition compound NCIT:C65107 treatment status body mass index disease stage HIPAA NCIT:C4870 individual CHEBI:27899 IV GDPR organism part Ann Arbor stage MONDO:0005044 ID NCIT:C18206 NCI NCIT:C15632 AJCC tumor grade NCIT:C53554 NCIT:C65108 MONDO:0005148 smoking status HANCESTRO:0005"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides detailed guidelines for data file metadata fields that require specific formatting or have complex standardization requirements. For basic field descriptions, see the main SDRF-Proteomics specification.\n\nVersion 1.0.0 - 2025-01\n\nCV Term Format\n\nFor data file metadata columns that reference ontology terms, use the structured CV term format:\n\nNT={term name};AC={accession}\n\nExamples:\n\n- Dissociation method: NT=HCD;AC=PRIDE:0000590\n- Fractionation method: NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564\n- Instrument: NT=Q Exactive HF;AC=MS:1002523\n- Label: NT=TMT126;AC=PRIDE:0000285\n\nWhy use the structured format?\n\n1. Automated annotation: Many data file properties (instrument, acquisition method, dissociation method) can be automatically determined by software from raw files.\n2. Validation: Accession numbers enable automated validation against ontologies.\n3. Interoperability: Structured terms are unambiguous across different tools and databases.\n\n Unlike sample metadata (characteristics) which are typically annotated manually using simple term names, data file metadata benefits from the structured CV term format because these values are often extracted programmatically from instrument files.\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119, iTRAQ121\n\nSILAC labels: SILAC light, SILAC medium, SILAC heavy\n\nMS2 Mass Analyzer\n\nColumn: comment[MS2 mass analyzer]\n\nOntology: PSI-MS - Mass analyzer type (MS:1000443)\n\nSpecifies the analyzer used for MS2 scans. Important for hybrid instruments.\n\nCommon values:\n\nAnalyzer |Accession\n\norbitrap |MS:100",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "TIP dissociation method OLS MS:1001917 NCE depletion README alkylation reagent IAA UNIMOD MS:1000264 MS:1000081 PRIDE:0000553 PRIDE:0000561 MOD DIA MT MS:1003246 cleavage agent details MS:1002631 TA MS:1001251 precursor mass tolerance MS:1000133 PRIDE:0000564 MS:1000598 IAM MS:1000484 MS:1001313 modification parameters MS MS:1000084 CAA MS:1001309 TCEP TOF NT REQUIRED reduction reagent UNIMOD:21 PSI PRIDE:0000590 SILAC UNIMOD:1 HCD SDS MS1 scan range NOTE PAGE DTT SH SCX MS:1002523 MS:1000443 AC MS:1000422 TMT MS:1001045 UVPD RECOMMENDED SDRF CID MS:1001306 CV MS2 mass analyzer UNIMOD:35 MS:1001303 ETD fractionation method PRIDE:0000285 PRIDE collision energy PRIDE:0000551 scan window lower limit UNIMOD:4 scan window upper limit fraction identifier PRIDE:0000565 label fragment mass tolerance HF exclamation PP"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides detailed guidelines for data file metadata fields that require specific formatting or have complex standardization requirements. For basic field descriptions, see the main SDRF-Proteomics specification.\n\nVersion 1.0.0 - 2025-01\n\nCV Term Format\n\nFor data file metadata columns that reference ontology terms, use the structured CV term format:\n\nNT={term name};AC={accession}\n\nExamples:\n\n- Dissociation method: NT=HCD;AC=PRIDE:0000590\n- Fractionation method: NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564\n- Instrument: NT=Q Exactive HF;AC=MS:1002523\n- Label: NT=TMT126;AC=PRIDE:0000285\n\nWhy use the structured format?\n\n1. Automated annotation: Many data file properties (instrument, acquisition method, dissociation method) can be automatically determined by software from raw files.\n2. Validation: Accession numbers enable automated validation against ontologies.\n3. Interoperability: Structured terms are unambiguous across different tools and databases.\n\n Unlike sample metadata (characteristics) which are typically annotated manually using simple term names, data file metadata benefits from the structured CV term format because these values are often extracted programmatically from instrument files.\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119, iTRAQ121\n\nSILAC labels: SILAC light, SILAC medium, SILAC heavy\n\nMS2 Mass Analyzer\n\nColumn: comment[MS2 mass analyzer]\n\nOntology: PSI-MS - Mass analyzer type (MS:1000443)\n\nSpecifies the analyzer used for MS2 scans. Important for hybrid instruments.\n\nCommon values:\n\nAnalyzer |Accession\n\norbitrap |MS:100",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "dissociation method OLS MS:1001917 NCE depletion alkylation reagent IAA UNIMOD MS:1000264 MS:1000081 PRIDE:0000553 PRIDE:0000561 MOD DIA MT MS:1003246 cleavage agent details MS:1002631 TA MS:1001251 precursor mass tolerance MS:1000133 PRIDE:0000564 MS:1000598 IAM MS:1000484 MS:1001313 modification parameters MS MS:1000084 CAA MS:1001309 TCEP TOF NT REQUIRED reduction reagent UNIMOD:21 PSI PRIDE:0000590 SILAC UNIMOD:1 HCD SDS MS1 scan range PAGE DTT SH SCX MS:1002523 MS:1000443 AC MS:1000422 TMT MS:1001045 UVPD RECOMMENDED SDRF CID MS:1001306 CV MS2 mass analyzer UNIMOD:35 MS:1001303 ETD fractionation method PRIDE:0000285 PRIDE collision energy PRIDE:0000551 scan window lower limit UNIMOD:4 scan window upper limit fraction identifier PRIDE:0000565 label fragment mass tolerance HF PP"
  }
];
